{
  "variant_id": {
    "Gene": "SNCA",
    "Protein_Change": {
      "ref": "A",
      "alt": "T",
      "position": "53"
    },
    "variant_string_id": "SNCA A53T"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "Alpha-synuclein mutations cause Parkinson's disease through gain-of-function mechanisms involving increased protein aggregation and neurotoxicity.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly defines the disease mechanism (gain-of-function via aggregation/neurotoxicity) and links it to the gene/protein function."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study uses a gain-of-function model involving protein aggregation and neurotoxicity assays, which are well-established for Parkinson's disease.",
      "judgment": "Yes",
      "reasoning": "The assay class (gain-of-function model) directly reflects the disease mechanism (aggregation/neurotoxicity) defined in Step 1.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The paper includes wild-type and mutant controls, and experiments were performed in triplicate.",
      "judgment": "Yes",
      "reasoning": "Both controls (wild-type vs. mutant) and replicates (triplicate experiments) are explicitly described in the paper.",
      "next_step_or_outcome": "Proceed to Sub-step 3c"
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "Known pathogenic variants (e.g., A53T) are used as controls in the study.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly uses known pathogenic variants as controls, satisfying Sub-step 3c criteria.",
      "next_step_or_outcome": "Proceed to Step 4"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The paper reports statistically significant p-values (<0.001) and effect sizes for increased aggregation and neurotoxicity.",
      "judgment": "Yes",
      "reasoning": "Statistical analyses (p-values, effect sizes) are sufficient to infer OddsPath > 18.7 (very strong pathogenic evidence).",
      "next_step_or_outcome": "Finalize strength"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The assay is validated, controls/replicates are present, and statistical significance (p < 0.001) supports a very strong PS3 pathogenic conclusion for SNCA A53T."
}